260 related articles for article (PubMed ID: 33068125)
1. Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice.
Nguyen-Tu MS; Martinez-Sanchez A; Leclerc I; Rutter GA; da Silva Xavier G
Diabetologia; 2021 Jan; 64(1):129-141. PubMed ID: 33068125
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.
Geoghegan G; Simcox J; Seldin MM; Parnell TJ; Stubben C; Just S; Begaye L; Lusis AJ; Villanueva CJ
Mol Metab; 2019 Jun; 24():44-63. PubMed ID: 30948248
[TBL] [Abstract][Full Text] [Related]
3. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.
da Silva Xavier G; Mondragon A; Sun G; Chen L; McGinty JA; French PM; Rutter GA
Diabetologia; 2012 Oct; 55(10):2667-2676. PubMed ID: 22717537
[TBL] [Abstract][Full Text] [Related]
4. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.
da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA
Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277
[TBL] [Abstract][Full Text] [Related]
6. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
7. The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.
Chen X; Ayala I; Shannon C; Fourcaudot M; Acharya NK; Jenkinson CP; Heikkinen S; Norton L
Diabetes; 2018 Apr; 67(4):554-568. PubMed ID: 29317436
[TBL] [Abstract][Full Text] [Related]
8. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the
Galderisi A; Tricò D; Pierpont B; Shabanova V; Samuels S; Dalla Man C; Galuppo B; Santoro N; Caprio S
Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor-7-like 2 (
Nguyen-Tu MS; da Silva Xavier G; Leclerc I; Rutter GA
J Biol Chem; 2018 Sep; 293(36):14178-14189. PubMed ID: 29967064
[TBL] [Abstract][Full Text] [Related]
10. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
13. Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice.
Bailey KA; Savic D; Zielinski M; Park SY; Wang LJ; Witkowski P; Brady M; Hara M; Bell GI; Nobrega MA
Hum Mol Genet; 2015 Mar; 24(6):1646-54. PubMed ID: 25398947
[TBL] [Abstract][Full Text] [Related]
14. Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction.
Bagchi DP; Li Z; Corsa CA; Hardij J; Mori H; Learman BS; Lewis KT; Schill RL; Romanelli SM; MacDougald OA
Mol Metab; 2020 Sep; 39():100992. PubMed ID: 32325263
[TBL] [Abstract][Full Text] [Related]
15. Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes.
Chen ZL; Shao WJ; Xu F; Liu L; Lin BS; Wei XH; Song ZL; Lu HG; Fantus IG; Weng JP; Jin TR
Cell Signal; 2015 Mar; 27(3):587-97. PubMed ID: 25550093
[TBL] [Abstract][Full Text] [Related]
16. TCF7 is not essential for glucose homeostasis in mice.
Kaur KD; Wong CK; Baggio LL; Beaudry JL; Fuchs S; Panaro BL; Matthews D; Cao X; Drucker DJ
Mol Metab; 2021 Jun; 48():101213. PubMed ID: 33741532
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice.
Whitham M; Pal M; Petzold T; Hjorth M; Egan CL; Brunner JS; Estevez E; Iliades P; Zivanovic B; Reibe S; Hughes WE; Findeisen M; Hidalgo J; Febbraio MA
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E597-E604. PubMed ID: 31386565
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner.
Sakhneny L; Rachi E; Epshtein A; Guez HC; Wald-Altman S; Lisnyansky M; Khalifa-Malka L; Hazan A; Baer D; Priel A; Weil M; Landsman L
Diabetes; 2018 Mar; 67(3):437-447. PubMed ID: 29246974
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice.
Yang H; Li Q; Lee JH; Shu Y
Int J Biol Sci; 2012; 8(6):791-801. PubMed ID: 22719219
[TBL] [Abstract][Full Text] [Related]
20. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
